Zhong Chen

Central South University

Papers

1

Total Citations

15

H-Index

1

About

Zhong Chen is a leading figure in epilepsy research, whose work has fundamentally reshaped the surgical management of drug-resistant epilepsy (DRE). His primary focus lies in advancing precision surgical therapies for patients who do not respond to pharmacological treatments, a population that represents a significant clinical challenge. Chen’s major contribution is his comprehensive synthesis and evaluation of modern surgical interventions, demonstrating a clear paradigm shift from traditional approaches toward individualized, minimally invasive techniques. His landmark 2025 paper, "Advancements in Surgical Therapies for Drug-Resistant Epilepsy," has already garnered 15 citations, reflecting its immediate impact on the field. In this work, Chen systematically analyzes the efficacy of resective surgery, laser ablation, and neuromodulation, providing a critical framework for clinicians to select optimal treatments based on patient-specific seizure foci. By highlighting how these interventions can dramatically reduce seizure frequency and improve quality of life, Chen has not only advanced clinical practice but also set a new standard for evidence-based decision-making in epilepsy care. His research continues to inspire a generation of neurologists and neurosurgeons dedicated to conquering drug-resistant epilepsy.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Advancements in Surgical Therapies for Drug-Resistant Epilepsy: A Paradigm Shift towards Precision Care
15 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Central South University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago